sophocarpine has been researched along with Disease Exacerbation in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Du, L; Hao, G; Li, L; Miao, W; Su, X; Zheng, H | 1 |
| Chen, G; Deng, X; Li, Y; Liu, W; Shi, Y; Sun, Y; Wang, F; Wu, W; Zeng, Q; Zhang, B; Zhou, L | 1 |
2 other study(ies) available for sophocarpine and Disease Exacerbation
| Article | Year |
|---|---|
Inhibition of Type-2 Diabetes Mellitus Development by Sophocarpine through Targeting PPARy-Regulated Gene Expression.
Topics: Alkaloids; Animals; Blood Glucose; Diabetes Mellitus, Type 2; Disease Progression; Dose-Response Relationship, Drug; Gene Expression Regulation; Hypoglycemic Agents; Male; Mice; Oxidative Stress; Peroxisome Proliferator-Activated Receptors | 2021 |
Targeting miR-21 with Sophocarpine Inhibits Tumor Progression and Reverses Epithelial-Mesenchymal Transition in Head and Neck Cancer.
Topics: Alkaloids; Animals; Cell Line, Tumor; Cell Movement; Cell Proliferation; Disease Models, Animal; Disease Progression; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Humans; Mice; MicroRNAs; Mutation; p38 Mitogen-Activated Protein Kinases; Xenograft Model Antitumor Assays | 2017 |